Search by Drug Name or NDC

    NDC 00409-1902-01 Procainamide Hydrochloride 100 mg/mL Details

    Procainamide Hydrochloride 100 mg/mL

    Procainamide Hydrochloride is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is PROCAINAMIDE HYDROCHLORIDE.

    Product Information

    NDC 00409-1902
    Product ID 0409-1902_71239e14-ba00-4819-bc9f-d802e09fcab3
    Associated GPIs 35100020102010
    GCN Sequence Number 000230
    GCN Sequence Number Description procainamide HCl VIAL 100 MG/ML INJECTION
    HIC3 A2A
    HIC3 Description ANTIARRHYTHMICS
    GCN 01100
    HICL Sequence Number 000076
    HICL Sequence Number Description PROCAINAMIDE HCL
    Brand/Generic Generic
    Proprietary Name Procainamide Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name PROCAINAMIDE HYDROCHLORIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 100
    Active Ingredient Units mg/mL
    Substance Name PROCAINAMIDE HYDROCHLORIDE
    Labeler Name Hospira, Inc.
    Pharmaceutical Class Antiarrhythmic [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA089069
    Listing Certified Through 2024-12-31

    Package

    NDC 00409-1902-01 (00409190201)

    NDC Package Code 0409-1902-01
    Billing NDC 00409190201
    Package 25 CARTON in 1 CASE (0409-1902-01) / 1 VIAL, MULTI-DOSE in 1 CARTON (0409-1902-11) / 10 mL in 1 VIAL, MULTI-DOSE
    Marketing Start Date 2006-03-08
    NDC Exclude Flag N
    Pricing Information N/A